Union Minister L Murugan launches several healthcare initiatives at ESIC Medical College in Chennai
The Union Minister reaffirmed the Centre's focus on strengthening healthcare infrastructure across the country and lauded Prime Minister Narendra Modi for several healthcare schemes.
After launching the healthcare initiatives, L Murugan said, 'I am pleased to participate in this event and launch several healthcare initiatives dedicated to the welfare of the people. After witnessing the facilities at the college, I could sense the care and commitment of Prime Minister Narendra Modi towards the well-being of workers.'
Highlighting the Centre's achievements over the past 11 years, the Minister said, 'Medical colleges and faculty have significantly increased across India. The number of medical seats has risen and will continue to expand in the coming years.'
He also said that the government was not only focusing on workers but was also extending support to persons with disabilities.
'The Pradhan Mantri Jan Aushadhi Kendras (Prime Minister's Medical Stores) have been set up to ensure affordable access to quality medicines for all. Our Prime Minister, Narendra Modi, is always concerned about the nation's health. That's why he implemented the Arogya Mandir scheme, Ayushman Bharat, and Jan Aushadhi Kendras,' he said.
'Apart from that, the medical college infrastructure has also increased. 75,000 new MBBS seats have been added. Every district now has a medical college, and the number of medical seats is rising... Before 2014, there were only 7 AIIMS, but in the last 11 years, 15 new AIIMS have been established in the country,' he added.
Murugan stressed the importance of preventive healthcare and urged citizens to reduce daily oil consumption by at least 10 per cent to lead healthier lives.
'India's medical infrastructure is growing rapidly, and many more development projects are in the pipeline. Every District should have a medical college,' he stated.
Earlier on Sunday, Union Health Minister JP Nadda and Delhi Chief Minister Rekha Gupta distributed appointment letters to 1400 nurses.
CM Gupta said that the government is making efforts to tackle the shortage of medical staff and medicines. Rekha Gupta told the reporters, 'It is a matter of great joy that, after many years in the history of the Delhi government, appointment letters for permanent nursing staff have been distributed by the government. F
For years, due to a shortage of staff, Delhi's hospitals have been running in a disorganised manner. The government has made significant efforts within its tenure to fill these vacancies, and today, approximately 1,400 nurses have been given appointment letters.'Delhi CM further congratulated the health department and the Health Ministry. (ANI)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
15 minutes ago
- Time of India
Ayushman Bharat wards to be set up at CHCs across Gorakhpur
Gorakhpur: Special wards under the Ayushman Bharat, Pradhan Mantri Jan Arogya Yojana (PM-JAY) will soon be operational at all Community Health Centres (CHCs) in Gorakhpur. The initiative kicked off at Piprauli CHC on Monday, where chief medical officer (CMO) Dr Rajesh Jha inaugurated a dedicated three-bed Ayushman Bharat ward. A beneficiary under the scheme has already been admitted. CMO Dr Jha, accompanied by ACMO (RCH) Dr A K Choudhary, also took part in a tree plantation drive under the 'Ek Ped Maa Ke Naam'campaign at Piprauli CHC. The CMO later inspected Bansgaon and Kohila CHCs. Dr Jha said all block-level medical officers have been instructed to establish similar Ayushman Bharat wards at their respective CHCs. These wards, he added, will offer better facilities than many private hospitals, encouraging rural patients to choose government-run centres for surgeries, deliveries, and other treatments. At Bansgaon CHC, discussions were held to identify space for setting up a Nagar Ayushman Arogya Mandir. Officials have been given a one-week deadline to finalize the location. However, during a surprise visit to Kohila CHC, Dr Jha found only one pharmacist on duty around 1:45 pm. Show-cause notices were issued to the absentee staff at Kohila and Piprauli CHCs. The CMO warned of strict action against staff arriving late or leaving early. He said senior officials will conduct regular field visits and attendance will be closely monitored through biometric systems.
India Gazette
3 hours ago
- India Gazette
No link between COVID-19 vaccines and sudden cardiac deaths, finds Karnataka expert panel
By Shalini Bhardwaj Bengaluru (Karnataka) [India], July 7 (ANI): A government-appointed expert committee in Karnataka has found no evidence linking COVID-19 infection or vaccination to the recent rise in sudden cardiac deaths in the state. In its official report, the panel concluded that the increase in such deaths appears to be multifactorial, with no single cause. It emphasized the need for greater public awareness about rising cardiovascular risks, especially among young adults. 'There is no single cause behind the observed rise in sudden cardiac deaths. Rather, it appears to be a multifactorial issue with behavioural, genetic, and environmental risks,' the report stated. 'While in the immediate post-COVID phase, there is an increase in the incidence of sudden cardiovascular events due to a pro-inflammatory state, this cannot be assumed to be true in the long term (>1 year). It has been three years since the end of the pandemic.' The report added that the investigation by this expert committee, constituted by the Government of Karnataka, highlights a growing public health challenge posed by the rise in sudden cardiovascular events, especially among young adults. The committee noted that conventional risk factors like hypertension, diabetes, dyslipidemia, and smoking were present in a majority of cases. However, 'a significant minority of patients presented with none of these, suggesting the possible involvement of novel or under-recognised mechanisms.' An observational study conducted at Jayadeva Hospital supported the committee's findings. 'The observational study conducted at Jayadeva Hospital did not find any association between premature cardiovascular disease and a prior history of Covid-19 infection or Covid vaccination,' the report stated. It further cited global research, stating that no causal link has been established between COVID-19 vaccines and sudden cardiac events. On the contrary, the report said, 'COVID-19 vaccination has been shown to be protective against cardiac events in the long term.' Earlier, while speaking to ANI, former ICMR DG Dr Balram Bhargava said that there is no link between COVID-19 vaccination and sudden deaths. 'There is no link between COVID-19 vaccination and sudden cardiac death in young people. A recent study by ICMR clearly demonstrates this,' he said. He pointed out that many such deaths involve identifiable risk factors, saying, 'We are hearing more about such deaths in people between 18 and 45. Still, these are associated with identifiable risk factors - over 50% of young individuals who die suddenly are smokers and have a history of binge drinking. Many are diabetics or have high cholesterol levels. Chewing tobacco is also reported in lower and middle strata that causes constriction of arteries, fat deposition and clot formation, which can block coronary arteries and lead to heart attacks.' Another major risk is heavy gymming and the use of unverified substances like steroids, hormones, and herbal supplements for bodybuilding. While going to the gym is good, it's dangerous to start intense workouts while consuming such substances suddenly.' Dr Bhargava also warned against excessive gym workouts combined with unregulated use of steroids, hormones, or herbal supplements. 'My advice to youth, especially around 20-25 years of age, is to know your numbers - weight, blood pressure, blood sugar and cholesterol levels. Take steps to correct them if they are not in range and avoid harmful habits. It's important to remember - many such deaths may have occurred earlier too, but went unnoticed,' he said. NITI Aayog Member (Health) Dr VK Paul reiterated the safety of COVID-19 vaccines, saying, 'Covid vaccines were tested after systematic laboratory studies, animal toxicity studies and clinical studies, and they fulfil scientific and all regulatory and benchmark criteria.' Referring to the ICMR study conducted across 47 hospital sites and published in 2023, Dr Paul said, 'More than 700 young individuals who suffered sudden deaths were included... What emerged was that the Covid vaccine was actually protective against sudden deaths, decreasing its risk... What was responsible for sudden death was - if the individual had a genetic tendency due to a family history of heart ailments, if one had suffered a more severe COVID-19 illness that required hospitalisation, smoking, and those who had consumed excess alcohol.' He added, 'Let's not be prey to unfounded notions.' Speaking with ANI, former AIIMS Delhi Director, Dr Randeep Guleria, said, 'There are reports of young people dying because of sudden cardiac arrests. There have been studies to look into this cause. If you look at studies from ICMR and AIIMS, they have clearly shown that these young deaths are not related to COVID-19 vaccines. COVID-19 vaccines do have some side effects, and all vaccines/drugs have some side effects, but the link between COVID-19 vaccination and heart attacks is not there. None of the studies have shown that...' Dr Saumitra Rawat, Chairperson, Institute of Surgical Gastroenterology, GI and HPB Onco-Surgery, and Liver Transplantation at Sir Ganga Ram Hospital, also emphasised the same. 'ICMR has done studies on the link between COVID-19 and sudden deaths, but there is no evidence to suggest that COVID-19 vaccination is linked to sudden cardiac death in young individuals. In fact, ICMR did a large-scale study in 2023, which found that the vaccine actually offered protection against such deaths. Sudden cardiac events in the 18-45 age group are often associated with identifiable risk factors such as a history of severe COVID-19, binge drinking, smoking, diabetes, high cholesterol, or sudden intense physical activity, especially when combined with unregulated supplements like steroids or hormones. Chewing tobacco, common in lower-income groups, also increases the risk by narrowing arteries and promoting clot formation,' he said. 'My message to the youth is clear: know your health numbers, avoid harmful habits, and make informed choices. COVID-19 vaccines are safe and protective; the real focus should be on addressing lifestyle risks,' he added. (ANI)
Time of India
5 hours ago
- Time of India
Union Minister Jitendra Singh inaugurates 'National Biobank' and India's own Longitudinal population data study at CSIR-IGIB
New Delhi: Union Minister of State (Independent Charge) for Science & Technology and Vice President of CSIR, Dr. Jitendra Singh, inaugurated the state-of-the-art Phenome India " National Biobank " at the CSIR-Institute of Genomics and Integrative Biology (IGIB) in the national capital today. The newly launched facility marks a significant stride towards building India's own longitudinal health database and enabling personalised treatment regimens in future, said the Ministry of Science and Technology. The Biobank will serve as the backbone of a nationwide cohort study, collecting comprehensive genomic, lifestyle, and clinical data from 10,000 individuals across India. Drawing inspiration from the UK Biobank model, the Indian version is tailored to capture the country's unique diversity across geography, ethnicity, and socio-economic backgrounds. Researchers believe the initiative will aid early diagnosis, improve therapeutic targeting, and bolster the fight against complex diseases such as diabetes, cancer, cardiovascular ailments, and rare genetic disorders, the Ministry added. "Today, we hold the promise of a future where every Indian may receive individualised treatment tailored to their genetic makeup, lifestyle, and environment," Dr. Jitendra Singh said while addressing the scientists and researchers at IGIB. "This transition to personalised healthcare is no longer theoretical--it is becoming reality, driven by indigenous innovations." Reflecting on the unique health challenges faced by Indians, Dr. Jitendra Singh noted the high prevalence of central obesity, a risk factor often underestimated. He highlighted past research showing that seemingly lean Indians may carry disproportionate fat around their waist, underlining the need for population-specific health strategies. "Our conditions are complex and deeply heterogeneous. This is where the Biobank becomes vital--it allows us to decode that complexity," he said. The Minister emphasised that India's scientific landscape is evolving rapidly, citing recent advances in quantum technology, CRISPR-based genome editing, and the fight against antimicrobial resistance (AMR). "India is no longer lagging behind--we are among the early adopters, sometimes even ahead," he said. The Biobank, he added, will complement these efforts by generating the kind of high-resolution data that can power AI-driven diagnostics and gene-guided therapies. Dr. Jitendra Singh also called for deeper collaboration between research institutions, government departments like the Department of Biotechnology, and industry partners, particularly in areas such as AMR and drug development. "Research must extend beyond the lab--it must find takers in the market and beneficiaries in society," he noted. The Phenome India Project , under which the Biobank has been launched, is designed to be a long-term, data-rich study tracking the health trajectories of individuals over several years. It will help scientists uncover disease patterns, gene-environment interactions, and response to therapies--all within the Indian context. Dr. N. Kalaiselvi, Director General of CSIR and Secretary, DSIR, commended the launch of the Biobank as a bold step toward India's self-reliance in healthcare data. Describing the initiative as a "baby step" with the potential to evolve into a global benchmark, she noted that the diversity and depth of the Indian cohort data could one day rival or even surpass global counterparts like the UK Biobank. Dr. Kalaiselvi highlighted CSIR's holistic efforts in areas like sickle cell anaemia through indigenous CRISPR-based therapies, affordable diagnostics, and collaborative interventions with tribal communities, while urging IGIB scientists to continue setting national examples in data-driven, people-centric research. Speaking at the occasion, Dr. Souvik Maiti, Director of CSIR-IGIB , reflected on the institute's pioneering role in genomics over the past two decades. "We were the first institute in India to begin decoding the human genome at a time when sequencing tools were practically non-existent," he said. Highlighting achievements such as the development of over 300 genetic diagnostics for rare disorders, extensive work on COVID-19 genome sequencing, and the launch of India's first drug genome project, he emphasised IGIB's mission of using global technologies to solve local health challenges. Dr. Maiti also pointed to ongoing work on women-centric studies, breast cancer genomics, and the development of indigenous CRISPR-based therapies for sickle cell disease, adding that IGIB's research now extends to domains like space biology and AI-based pilot fitness assessments in collaboration with the Indian Air Force. (ANI)
